Akums Drugs and Pharmaceuticals Limited has intimated the National Stock Exchange of India Ltd and BSE Limited about its scheduled participation in an investors/analysts meet. The disclosure is made pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company will participate in the following meet:
- Event Name: Emkay Confluence 2026 – India: Full Throttle Ahead
- Date & Time: 14th August, 2026, starting at 09:00 AM IST
- Type of Meet: Group Meet
- Location/Mode: Grand Hyatt, Mumbai / Physical mode
The company specifically states that no unpublished price sensitive information pertaining to the company will be shared with analysts/investors during this meet.
The disclosure notes that the schedule may be subject to change due to exigencies on the part of investors/analysts or the company.
A copy of this disclosure has been updated on the company's website at www.akums.in.